Skip to main content
Livermore
Livermore
ZHEN

Qube Research & Technologies Ltd

SEC CIK
0001729829
Latest filing
Aug 14, 2026

AVNS holding history

Avanos Medical, Inc. in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVNS overviewAll 13F holders of AVNSFull Q2 2026 holdings

Shares (Q2 2026)
554,350
Value
$13.8M
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of AVNS by Qube Research & Technologies Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026554,350$13.8M<0.1%+424,757+327.8%AddedHolders
Q1 2026129,593$1.82M<0.1%−573,322−81.6%ReducedHolders
Q4 2025702,915$7.89M<0.1%−24,923−3.4%ReducedHolders
Q3 2025727,838$8.41M<0.1%+102,429+16.4%AddedHolders
Q2 2025625,409$7.66M<0.1%+153,547+32.5%AddedHolders
Q1 2025471,862$6.76M<0.1%+360,071+322.1%AddedHolders
Q4 2024111,791$1.78M<0.1%+111,791NewHolders
Q3 20240$00.0%−38,002−100.0%Sold outHolders
Q2 202438,002$757.0K<0.1%−65,418−63.3%ReducedHolders
Q1 2024103,420$2.06M<0.1%−160.0%ReducedHolders
Q4 2023103,436$2.32M<0.1%+30,203+41.2%AddedHolders
Q3 202373,233$1.48M<0.1%+57,040+352.3%AddedHolders
Q2 202316,193$413.9K<0.1%+16,193NewHolders
Q4 20220$00.0%−18,032−100.0%Sold outHolders
Q3 202218,032$393.0K<0.1%−1,168−6.1%ReducedHolders
Q2 202219,200$525.0K<0.1%−9,408−32.9%ReducedHolders
Q1 202228,608$958.0K<0.1%+28,608NewHolders
Q4 20210$00.0%−8,899−100.0%Sold outHolders
Q3 20218,899$278.0K<0.1%−7,126−44.5%ReducedHolders
Q2 202116,025$583.0K<0.1%+6,898+75.6%AddedHolders
Q1 20219,127$399.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.